Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC45H57NO16 |
InChIKeyXABQIVHXGOOBAN-KWKVIRTPSA-N |
CAS Registry675584-79-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IT | 23 Oct 2009 |